Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 4/20 | 0.72 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.72 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.69 |
| ▸ | BCHE | P06276 | 2/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.38 |
| ▸ | RPS6KA5 | O75582 | 2/20 | 0.36 |
| ▸ | MAPKAPK2 | P49137 | 2/20 | 0.36 |
| ▸ | F10 | P00742 | 1/20 | 0.34 |
| ▸ | CDC25B | P30305 | 1/20 | 0.34 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | PNLIP | P16233 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phyllocladene SCHEMBL29437839 | 1.00 | HSD11B1 (0.72) | HSD11B1HSD11B2PTPN1BCHEACHE | |
| Phyllocladene SCHEMBL1006869 | 1.00 | HSD11B1 (0.72) | HSD11B1HSD11B2PTPN1BCHEACHE | |
| Phyllocladene SCHEMBL156928 | 1.00 | HSD11B1 (0.72) | HSD11B1HSD11B2PTPN1BCHEACHE | |
| Phyllocladene SCHEMBL1006868 | 1.00 | HSD11B1 (0.72) | HSD11B1HSD11B2PTPN1BCHEACHE | |
| Phyllocladene SCHEMBL16414456 | 0.88 | PTPN1 (0.65) | HSD11B1HSD11B2PTPN1BCHEACHE | |
| Phyllocladene SCHEMBL20538769 | 0.88 | PTPN1 (0.65) | HSD11B1HSD11B2PTPN1BCHEACHE | |
| SCHEMBL267551 | 0.84 | HSD11B1 (1.00) | HSD11B1HSD11B2PTPN1BCHEACHE | |
| SCHEMBL20738425 | 0.84 | HSD11B1 (1.00) | HSD11B1HSD11B2PTPN1BCHEACHE | |
| SCHEMBL3491660 | 0.84 | HSD11B1 (1.00) | HSD11B1HSD11B2PTPN1BCHEACHE | |
| SCHEMBL21331728 | 0.84 | HSD11B1 (1.00) | HSD11B1HSD11B2PTPN1BCHEACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11380884-B2 | Liquid composition for producing electrode composite material, method for producing electrode, and method for producing electrochemical element | RICOH COMPANY, LTD. (JP) | 2022-07-05 | — | — | US | claimed |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2026-02-05 | — | — | US | disclosed |
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC (US) | 2026-01-29 | — | — | US | disclosed |
| EP-4673510-A1 | SOLVENT-BASED INKJET INKS | Kao Corporation (JP) | 2026-01-07 | — | — | EP | disclosed |
| US-12458653-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2025-11-04 | — | — | US | disclosed |
| EP-4640783-A1 | TWO-PART CURABLE ADHESIVE, MULTILAYER BODY AND PACKAGE | DIC Corporation (JP) | 2025-10-29 | — | — | EP | disclosed |
| US-12427176-B2 | Enriched mineral pitch resin products and methods of manufacturing enriched mineral pitch resin products | RIZUN NODARI (US) | 2025-09-30 | — | — | US | disclosed |
| EP-3593390-B1 | FILM ELECTRODE, RESIN LAYER FORMING INK AND ELECTRODE PRINTING METHOD | RICOH CO LTD (JP) | 2025-09-17 | — | — | EP | disclosed |
| EP-4567936-A2 | FILM ELECTRODE, RESIN LAYER FORMING INK AND ELECTRODE PRINTING METHOD | Ricoh Company, Ltd. (JP) | 2025-06-11 | — | — | EP | disclosed |
| US-12303488-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2025-05-20 | — | — | US | disclosed |
| US-11684604-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2023-06-27 | — | — | US | disclosed |
| US-20230181665-A1 | TREATING OR PREVENTING INFLAMMATORY DISEASES INCLUDING DIABETES MELLITUS 10 TYPE I AND TYPE II AND THYROID DISEASES | Novel Concepts Medical Ltd (IL) | 2023-06-15 | — | — | US | disclosed |
| US-20230134432-A1 | COMPOSITIONS AND METHODS FOR TREATING SOLID AND SOFT TUMORS AND PROLIFERATIVE DISEASES | Novel Concepts Medical Ltd (IL) | 2023-05-04 | — | — | US | disclosed |
| US-20230091130-A1 | FILM ELECTRODE, RESIN LAYER FORMING INK, INORGANIC LAYER FORMING INK, AND ELECTRODE PRINTING APPARATUS | RICOH COMPANY, LTD. (JP) | 2023-03-23 | — | — | US | disclosed |
| US-11588147-B2 | Film electrode, resin layer forming ink, inorganic layer forming ink, and electrode printing apparatus | RICOH COMPANY, LTD. (JP) | 2023-02-21 | — | — | US | disclosed |
| WO-2022260020-A1 | METHOD FOR ADJUSTING QUANTITY OF LIQUID RETURNED TO STORAGE CONTAINER FOR LIQUID PREPARATION IN INVERTED VOLATILIZATION DEVICE, AND INVERTED VOLATILIZATION DEVICE | アース製薬株式会社 | 2022-12-15 | — | — | WO | disclosed |
| US-20220387537-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2022-12-08 | — | — | US | disclosed |
| US-11380884-B2 | Liquid composition for producing electrode composite material, method for producing electrode, and method for producing electrochemical element | RICOH COMPANY, LTD. (JP) | 2022-07-05 | — | — | US | disclosed |
| US-20220085458-A1 | POROUS INSULATOR, ELECTRODE, AND NONAQUEOUS POWER STORAGE ELEMENT | RICOH COMPANY, LTD. (JP) | 2022-03-17 | — | — | US | disclosed |
| US-11258136-B2 | Porous insulator, electrode, and nonaqueous power storage element | RICOH COMPANY, LTD. (JP) | 2022-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11684604-B2 | Cannabis based therapeutic and method of use | CNR2, CNR1, OPRK1 | HSD11B1 3153/4885HSD11B2 3207/4885PTPN1 2536/4885 |
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | CNR1, CNR2, OPRM1 | HSD11B1 406/4885HSD11B2 840/4885PTPN1 1893/4885 |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | TRPV1, SOST, RUNX1 | HSD11B1 674/4885HSD11B2 640/4885PTPN1 4282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.